OPKO Health, Inc. (OPK) Makes Progress on Game changing Covid-19 Treatment

OPKO Health, Inc. (NASDAQ:OPK) is one of the best healthcare penny stocks to buy according to hedge funds. On April 9, H.C. Wainwright reiterated its Buy rating on Opko Health (NASDAQ:OPK) and $3 price target, impressed by the company’s Phase 1 trial of a Covid-19 prevention treatment.

OPKO Health, Inc. (OPK) Makes Progress on Game changing Covid-19 Treatment

The company is currently working on MDX2301, a tetravalent bispecific antibody that shows tremendous potential for neutralizing all known variants of SARS-CoV-2. Opko Health has already conducted a Phase 1 trial of the candidate drug and dosed the first participants. It evaluated the safety and tolerability in healthy adults and adults at higher risk of severe COVID-19.

Opko Health (NASDAQ:OPK) is funding the COVID-19 program in its entirety with federal funds from the US Department of Health and Human Services Administration. H.C. Wainwright is confident that the company will deliver positive pharmacokinetic and immunogenicity data from the study before year-end. In addition, the research firm remains optimistic about MDX2301’s prospects for neutralizing all known variants and delivering broader, more durable protection against COVID-19.

OPKO Health, Inc. (NASDAQ:OPK) is a multinational biopharmaceutical and diagnostics company that discovers, develops, and commercializes pharmaceutical products and operates clinical laboratories. It focuses on treating serious diseases through products such as RAYALDEE and NGENLA, while also providing diagnostic services.

While we acknowledge the risk and potential of OPK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OPK and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 7 Penny Stocks That Aren’t Scams: Best Cheap Stocks to Buy and 8 Best Small-Cap Value Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.